Controlled Drug Release Systems for Cerebrovascular Diseases

3Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review offers a comprehensive exploration of optimized drug delivery systems tailored for controlled release and their crucial role in addressing cerebrovascular diseases. Through an in-depth analysis, various controlled release methods, including nanoparticles, liposomes, hydrogels, and other emerging technologies are examined. Highlighting the importance of precise drug targeting, it is delved into the underlying mechanisms of these delivery systems and their potential to improve therapeutic outcomes while minimizing adverse effects. Additionally, the specific applications of these optimized drug delivery systems in treating cerebrovascular disorders such as ischemic stroke, cerebral aneurysms, and intracranial hemorrhage are discussed. By shedding light on the advancements in drug delivery techniques and their implications in cerebrovascular medicine, this review offers valuable insights into the future of therapeutic interventions in neurology.

Cite

CITATION STYLE

APA

Martín-Morales, C., Caspani, S., Desco, M., Tavares de Sousa, C., & Gómez-Gaviro, M. V. (2025, January 1). Controlled Drug Release Systems for Cerebrovascular Diseases. Advanced Therapeutics. John Wiley and Sons Inc. https://doi.org/10.1002/adtp.202400239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free